Wound Care (Pharmacies) - Belarus

  • Belarus
  • Revenue in the Wound Care market is projected to reach US$1.53m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.52%, resulting in a market volume of US$1.57m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.16 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Belarus is experiencing steady growth due to customer preferences for effective and accessible healthcare products, as well as the increasing prevalence of chronic wounds and injuries. Customer preferences in the Wound Care (Pharmacies) market in Belarus are largely driven by the desire for products that are both effective and convenient to use. Customers are increasingly seeking wound care products that can provide quick relief and promote faster healing. They also value products that are easy to apply and can be used at home without the need for medical supervision. This preference for self-care and convenience has led to a rise in demand for over-the-counter wound care products available in pharmacies. Trends in the market include the growing adoption of advanced wound care products in Belarus. These products, such as hydrocolloid dressings and foam dressings, offer superior wound healing properties compared to traditional wound care products. They provide a moist environment for wound healing, promote faster tissue regeneration, and reduce the risk of infection. As customers become more aware of the benefits of advanced wound care products, the demand for these products is expected to increase. Another trend in the Wound Care (Pharmacies) market in Belarus is the rising prevalence of chronic wounds and injuries. Factors such as an aging population, an increase in non-communicable diseases, and a higher incidence of accidents and injuries contribute to the growing number of chronic wounds in the country. This has created a significant demand for wound care products that can effectively manage and treat chronic wounds, such as diabetic foot ulcers and pressure ulcers. Local special circumstances in Belarus also play a role in the development of the Wound Care (Pharmacies) market. The country has a well-established healthcare system that provides universal access to healthcare services, including wound care. This ensures that a wide range of wound care products are available in pharmacies across the country, making them easily accessible to the population. Additionally, the government has implemented policies to promote the use of advanced wound care products and improve the quality of wound care services, further driving the growth of the market. Underlying macroeconomic factors, such as GDP growth and healthcare expenditure, also contribute to the development of the Wound Care (Pharmacies) market in Belarus. As the economy continues to grow, consumers have more disposable income to spend on healthcare products, including wound care. Furthermore, increased healthcare expenditure by the government allows for the expansion and improvement of healthcare services, including wound care facilities. These factors create a favorable environment for the growth of the Wound Care (Pharmacies) market in Belarus. In conclusion, the Wound Care (Pharmacies) market in Belarus is developing due to customer preferences for effective and convenient healthcare products, the increasing prevalence of chronic wounds, and the availability of a wide range of wound care products in pharmacies. The adoption of advanced wound care products, the accessibility of healthcare services, and favorable macroeconomic factors further contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)